secwatch / observer
8-K filed November 12, 2026, 4:20 PM ET ticker SCTX CIK 0001853921
earnings confidence high sentiment neutral materiality 0.45

Scribe Therapeutics Q3 2026 net loss $9.9M ($0.68/sh); $174.2M cash funds operations into 1H 2029

Scribe Therapeutics, Inc.

Scribe Therapeutics, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-26-458486
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4.1-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.